Radiopharma start-up raises $175 million - Chemical

Oct 13, 2024 · Aktis Oncology, a radiopharmaceutical firm that launched in 2021, has raised $175 million in a series B financing round co-led by RA Capital Management, RTW Investments, …

CouponFollow Extension

$175
OFF

Radiopharma Start-up Raises $175 Million - Chemical

4 weeks from now

Oct 13, 2024 · Aktis Oncology, a radiopharmaceutical firm that launched in 2021, has raised $175 million in a series B financing round co-led by RA Capital Management, RTW Investments, …

acs.org

$175
OFF

Lilly-partnered Radiopharma Startup Aktis Oncology Raises $175M

4 weeks from now

Sep 30, 2024 · Lilly is also partnered with the startup on radiopharmaceuticals for therapeutic and diagnostic applications, through a $60 million upfront deal this spring. With the Series B, Aktis …

mwbn.bio

$175
OFF

Lilly-partnered Radiopharma Startup Aktis Oncology Raises $175M

4 weeks from now

Sep 30, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$175
OFF

Aktis Raises $175M To Fuel Radiopharma Drug Development

4 weeks from now

Sep 30, 2024 · Sign up for the latest from Aktis Oncology. Email address: Leave this field empty if you're human: Contact Us

aktisoncology.com

$175
OFF

Lilly-partnered Radiopharma Startup Aktis Oncology Raises $175M

4 weeks from now

Sep 30, 2024 · As other young radiopharmaceutical companies get acquired by drugmakers, Boston-based Aktis Oncology wants to become one of the field's next hot startups. On …

endpts.com

$175
OFF

Mariana Reels In $175M For Radiopharmaceutical Pipeline - Fierce …

4 weeks from now

Sep 7, 2023 · The preclinical company will use the $175 million to help transition into human trials, with a particular focus on lead asset MC-339. The precision, next-generation …

fiercebiotech.com

$175
OFF

Radiopharma Start-up Alpha-9 Oncology Secures $175 Million

4 weeks from now

Oct 24, 2024 · Alpha-9 Oncology, a Canadian radiopharmaceutical firm, has raised $175 million in an oversubscribed Series C round led by Lightspeed Venture Partners and Ascenta Capital. …

thepharmaletter.com

$175
OFF

Radiopharma Startup Alpha-9 Nets $175M Series C

4 weeks from now

Oct 24, 2024 · In the latest deal for the red-hot radiopharmaceutical field, Alpha-9 Oncology announced an oversubscribed $175 million series C financing to support advancement of its …

insideprecisionmedicine.com

$175
OFF

Radiopharma Alpha-9 Raises $175M Series C To Fund Clinical Push

4 weeks from now

Oct 23, 2024 · Alpha-9 Oncology has raised a $175M series C for its radiopharma ... a $11 million series A in 2021 and a $75 million series B the ... Samsara BioCapital returned for today’s raise.

fiercebiotech.com

$175
OFF

Startup Mariana Raises $175M For Radiopharmaceutical Drug Research

4 weeks from now

Sep 7, 2023 · Mariana Oncology, a biotechnology company developing radiopharmaceuticals for cancer, has raised $175 million in a Series B round. The fundraising, announced by Mariana …

biopharmadive.com

$175
OFF

Radiopharma Biotech Alpha-9 Oncology Closes $175M Series C …

4 weeks from now

Oct 23, 2024 · Another private radiopharmaceutical biotech has raised big money. Alpha-9 Oncology revealed on Wednesday that it’s put together a $175 million Series C, aiming to fund …

endpts.com

$60
OFF

Lilly Partners With Aktis, Deepening Radiopharma Investment

4 weeks from now

May 21, 2024 · Eli Lilly is partnering with biotechnology company Aktis Oncology to develop radiopharmaceuticals for cancer, agreeing to a deal that will pay the startup $60 million …

biopharmadive.com

$22
OFF

Radiopharmaceutical Firm Pentixapharm Raises $22M Through …

4 weeks from now

Oct 7, 2024 · Germany-based radiopharmaceutical firm Pentixapharm has raised nearly $22 million (USD) through an initial public stock offering, the company announced Oct. 1. ...

radiologybusiness.com

$142
OFF

Abdera Raises $142 Million For Radiopharmaceutials

4 weeks from now

Apr 30, 2023 · Radiopharma start-up raises $175 million Belgian biotech firm Confo Therapeutics raises $65 million ... Chemical & Engineering News will not share your email address with any …

acs.org

FAQs about Radiopharma start-up raises $175 million - Chemical Coupon?

Why do radiopharmaceuticals need Timing?

Treatment requires precisely timing delivery to ensure the radioisotopes the drugs contain don’t decay to a point where they are less effective. Aktis is developing alpha-emitting radiopharmaceuticals, so called for the type of radioactive particle they emit. ...

Why did aktis invest in radiopharma?

Aktis’ funding is further evidence of industry interest in radiopharma, which have enticed investors as an alternative way to precisely target tumors. The field has benefited from the success of Novartis’ radiopharma drugs Pluvicto and Lutathera, the former of which analysts predict could eventually earn over $2 billion a year. ...

How much did Mariana oncology raise in a series B round?

Mariana Oncology, a biotechnology company developing radiopharmaceuticals for cancer, raised $175 million in their Series B round. The fundraising, announced by Mariana Thursday, was led by Deep Track Capital and Forbion, a European venture capital firm that recently raised more than $800 million to invest in young biotechs. ...

Can radiopharmaceuticals help in treating cancer?

Radiopharmaceuticals are viewed as a promising approach to delivering radiation to the body in a more targeted way for cancer treatment. While radiation therapy is a mainstay of cancer care, it can come with harsh side effects and can inadvertently damage healthy tissue. ...

Which pharma companies are stepping in?

A large number of startups are active, providing plentiful deal targets for the large pharma companies that are now stepping in. Last year, Bristol Myers agreed to spend $4.1 billion to buy RayzeBio, while Eli Lilly acquired Point Biopharma for $1.4 billion. ...

What is the difference between radiation therapy and radiopharmaceuticals?

Radiation therapy and radiopharmaceuticals are both used in cancer care, but they differ in their approach. Radiation therapy exposes the tumor to radiation from an external source, which can come with harsh side effects and can inadvertently damage healthy tissue. By comparison, radiopharmaceuticals introduce radiation directly into tumors by pairing a radioactive isotope with a targeting compound. ...